Objective: To study the efficiency and safety of PGE1 - CD intravenous infusion in the treatment of PAOD.
目的：临床评价静脉给保达新(PGE1·CD)治疗PAOD的有效性及安全性。
Objective to determine the effectiveness and safety of PGE1 in patients with chronic renal failure (CRF) and to provide the proof of evidence-based pharmacy.
目的系统评价前列腺素e1治疗慢性肾功能衰竭的疗效和安全性，为临床选用前列腺素e1治疗该病提供循证药学证据。
Conclusions PGE1 treatment during recipient operation could increase one-week survival rate, which might be related with its stabilizing effect on lysosome membrane.
结论术中应用PGE1能显著提高大鼠肝移植后的1周存活率，其机制可能与PGE1稳定溶酶体膜的作用有关。
应用推荐